Center for Health Care Research & Policy

Featured News Article

Digoxin one of the oldest and least expensive drugs for heart failure was found to improve patient outcomes in an article
In the European Heart Journal, Dr. Ali Ahmed and colleagues (including Thomas E. Love, Ph.D., of the Center for Health Care Research and Policy) studied the effectiveness of digoxin for heart failure. The study included a comprehensive re-analysis of data from the Digitalis Investigators Group trial sponsored in the early 1990s by the National Heart, Lung and Blood Institute. In the new article, the investigators found that administering low doses of digoxin to heart failure patients both improved their chances of survival and reduced their average number of future hospitalizations for heart failure. The results suggest that digoxin should play an important role in treating heart failure patients who continue to have symptoms despite the use of more expensive drugs such as ACE inhibitors or beta-blockers. (posted 1/2006)

Home | About Us | Contact Us